1. Home
  2. INTA vs ICUI Comparison

INTA vs ICUI Comparison

Compare INTA & ICUI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Intapp Inc.

INTA

Intapp Inc.

HOLD

Current Price

$23.29

Market Cap

3.2B

Sector

Technology

ML Signal

HOLD

Logo ICU Medical Inc.

ICUI

ICU Medical Inc.

HOLD

Current Price

$144.57

Market Cap

3.8B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
INTA
ICUI
Founded
2000
1984
Country
United States
United States
Employees
N/A
N/A
Industry
Computer Software: Prepackaged Software
Medical/Dental Instruments
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
3.2B
3.8B
IPO Year
2021
1992

Fundamental Metrics

Financial Performance
Metric
INTA
ICUI
Price
$23.29
$144.57
Analyst Decision
Buy
Buy
Analyst Count
8
5
Target Price
$50.25
$179.50
AVG Volume (30 Days)
1.7M
261.5K
Earning Date
02-03-2026
02-19-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$543,341,000.00
$2,320,363,000.00
Revenue This Year
$15.66
N/A
Revenue Next Year
$13.37
N/A
P/E Ratio
N/A
N/A
Revenue Growth
16.84
N/A
52 Week Low
$20.76
$107.00
52 Week High
$77.74
$165.17

Technical Indicators

Market Signals
Indicator
INTA
ICUI
Relative Strength Index (RSI) 19.23 41.93
Support Level $22.88 $140.66
Resistance Level $26.32 $155.90
Average True Range (ATR) 2.19 5.06
MACD -0.63 -1.12
Stochastic Oscillator 14.56 23.56

Price Performance

Historical Comparison
INTA
ICUI

About INTA Intapp Inc.

Intapp Inc is a provider of industry-specific, cloud-based software solutions for the professional and financial services industry. It empowers private capital,g, legal, accounting, and consulting firms with the technology needed to meet rapidly changing client, investor, and regulatory requirements. Geographically, it derives a majority of its revenue from the United States and also has a presence in the United Kingdom and the Rest of the world.

About ICUI ICU Medical Inc.

ICU Medical is a California-based pure-play infusion therapy company that provides consumables, systems, and services for virtually every component of the IV continuum of care. ICU has become one of the largest players in its industry following its acquisition of Hospira Infusion Systems from Pfizer in 2017 and Smiths Medical from Smiths Group in 2022. It holds top-tier positions across its three reporting segments: consumables (50% of consolidated revenue), infusion systems (30%), and vital care (20%). The combined entity remains primarily US-focused, generating over 60% of its sales domestically.

Share on Social Networks: